Literature DB >> 21098110

OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .

Josh Torgovnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21098110     DOI： 10.1177/0333102410388529

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  2 in total

Review 1.  OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

2.  Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.

Authors:  Haifeng Zhang; Yajun Lian; Yunqing Ma; Yuan Chen; Caihong He; Nanchang Xie; Chuanjie Wu
Journal:  J Headache Pain       Date:  2014-09-27       Impact factor: 7.277
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.